229
Views
19
CrossRef citations to date
0
Altmetric
Research Articles

Treatment of breast cancer with engineered novel pH-sensitive triaryl-(Z)-olefin niosomes containing hydrogel: an in vitro and in vivo study

ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 126-135 | Received 09 Feb 2019, Accepted 26 Mar 2019, Published online: 23 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Heba F. Salem, Mohamed Mahmoud Nafady, Mohamed Gamal EL-Din Ewees, Hend Hassan & Rasha A. Khallaf. (2022) Rosuvastatin calcium-based novel nanocubic vesicles capped with silver nanoparticles-loaded hydrogel for wound healing management: optimization employing Box–Behnken design: in vitro and in vivo assessment. Journal of Liposome Research 32:1, pages 45-61.
Read now

Articles from other publishers (18)

Ali Moammeri, Masoumeh Mirzaei Chegeni, Hamidreza Sahrayi, Robabehbeygom Ghafelehbashi, Farkhondeh Memarzadeh, Afsoun Mansouri, Iman Akbarzadeh, Maryam Sadat Abtahi, Faranak Hejabi & Qun Ren. (2023) Current advances in niosomes applications for drug delivery and cancer treatment. Materials Today Bio 23, pages 100837.
Crossref
Zahra Saeidi, Rashin GitiMehdi RostamiFarhad Mohammadi. (2023) Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma. Advanced Pharmaceutical Bulletin 13:4, pages 646-662.
Crossref
Sheng Sun, Ye-hui Wang, Xiang Gao, He-yong Wang, Lu Zhang, Na Wang, Chun-mei Li & Shao-quan Xiong. (2023) Current perspectives and trends in nanoparticle drug delivery systems in breast cancer: bibliometric analysis and review. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Heba A. Abou-Taleb, Basmah Nasser Aldosari, Randa Mohammed Zaki, Obaid Afzal, Alaa S. Tulbah, Mary Girgis Shahataa, Fatma I. Abo El-Ela, Heba F. Salem & Amr Gamal Fouad. (2023) Formulation and Therapeutic Evaluation of Isoxsuprine-Loaded Nanoparticles against Diabetes-Associated Stroke. Pharmaceutics 15:9, pages 2242.
Crossref
Amr Gamal Fouad, Mohammed R. A. Ali, Demiana M. Naguib, Hanan O. Farouk, Mohamed I. Zanaty & Fatma I. Abo El-Ela. (2023) Design, optimization, and in vivo evaluation of invasome-mediated candesartan for the control of diabetes-associated atherosclerosis. Drug Delivery and Translational Research.
Crossref
Thaaranni Bashkeran, Azlina Harun Kamaruddin, Trung Xuan Ngo, Kazuma Suda, Hiroshi Umakoshi, Nozomi Watanabe & Masrina Mohd Nadzir. (2023) Niosomes in cancer treatment: A focus on curcumin encapsulation. Heliyon 9:8, pages e18710.
Crossref
Jonaid Ahmad Malik, Jeba Ajgar Ansari, Sakeel Ahmed, Afreen Khan, Nafees Ahemad & Sirajudheen Anwar. (2023) Nano-drug delivery system: a promising approach against breast cancer. Therapeutic Delivery 14:5, pages 357-381.
Crossref
Heba F. Salem, Amr Gamal, Haitham Saeed, Marwa Kamal & Alaa S. Tulbah. (2022) Enhancing the Bioavailability and Efficacy of Vismodegib for the Control of Skin Cancer: In Vitro and In Vivo Studies. Pharmaceuticals 15:2, pages 126.
Crossref
Priyadarshi Aparajay & Abhimanyu Dev. (2022) Functionalized niosomes as a smart delivery device in cancer and fungal infection. European Journal of Pharmaceutical Sciences 168, pages 106052.
Crossref
Hazal Ezgi Gültekin, Ezgi Oner, Miray İlhan & Merve Karpuz. 2022. Applications of Nanovesicular Drug Delivery. Applications of Nanovesicular Drug Delivery 115 148 .
Abhinav Raut & Nanasaheb D. Thorat. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors 329 345 .
Heba F. Salem, Amr Gamal, Haitham Saeed & Alaa S. Tulbah. (2021) The Impact of Improving Dermal Permeation on the Efficacy and Targeting of Liposome Nanoparticles as a Potential Treatment for Breast Cancer. Pharmaceutics 13:10, pages 1633.
Crossref
Amr Gamal, Haitham Saeed, Fatma I. Abo El-Ela & Heba F. Salem. (2021) Improving the Antitumor Activity and Bioavailability of Sonidegib for the Treatment of Skin Cancer. Pharmaceutics 13:10, pages 1560.
Crossref
Fernanda Andrade, Maria Mercé Roca-Melendres, Esteban F. Durán-Lara, Diana Rafael & Simó SchwartzJr.Jr.. (2021) Stimuli-Responsive Hydrogels for Cancer Treatment: The Role of pH, Light, Ionic Strength and Magnetic Field. Cancers 13:5, pages 1164.
Crossref
Fatma I. Abo El-Ela, Khaled H. Hussein, Hossny A. El-Banna, Amr Gamal, Sherin Rouby, Ahmed M. S. Menshawy, EL-Shimaa EL-Nahass, Shehata Anwar, Mohamed M. A. Zeinhom, Heba F. Salem, Marawa Ahmed Yahia Al-Sayed, Hala A. El-Newery, Khaled A. M. Shokier, Khalid A. EL-Nesr & H. I. Hosein. (2020) Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan–Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study. AAPS PharmSciTech 21:8.
Crossref
Amr Gamal, Haitham Saeed, Ossama M. Sayed, Rasha M. Kharshoum & Heba F. Salem. (2020) Proniosomal Microcarriers: Impact of Constituents on the Physicochemical Properties of Proniosomes as a New Approach to Enhance Inhalation Efficiency of Dry Powder Inhalers. AAPS PharmSciTech 21:5.
Crossref
F. Amr Gamal, Rasha M. Kharshoum, Ossama M. Sayed, Fatma I. Abo El-Ela & Heba F. Salem. (2020) Control of basal cell carcinoma via positively charged ethosomes of Vismodegib: In vitro and in vivo studies. Journal of Drug Delivery Science and Technology 56, pages 101556.
Crossref
Amr Gamal F, Ossama M. Sayed, Fatma I. Abo El-Ela, Rasha M. Kharshoum & Heba F. Salem. (2020) Treatment of Basal Cell Carcinoma Via Binary Ethosomes of Vismodegib: In Vitro and In Vivo Studies. AAPS PharmSciTech 21:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.